123 related articles for article (PubMed ID: 26093645)
1. ViibraTip for Testing Vibration Perception to Detect Diabetic Peripheral Neuropathy: A NICE Medical Technology Guidance.
Willits I; Cole H; Jones R; Dimmock P; Arber M; Craig J; Sims A
Appl Health Econ Health Policy; 2015 Aug; 13(4):315-24. PubMed ID: 26093645
[TBL] [Abstract][Full Text] [Related]
2. Parafricta Bootees and Undergarments to Reduce Skin Breakdown in People with or at Risk of Pressure Ulcers: A NICE Medical Technologies Guidance.
Meads C; Glover M; Dimmock P; Pokhrel S
Appl Health Econ Health Policy; 2016 Dec; 14(6):635-646. PubMed ID: 27116358
[TBL] [Abstract][Full Text] [Related]
3. Quantitative assessment of diabetic peripheral neuropathy with use of the clanging tuning fork test.
Oyer DS; Saxon D; Shah A
Endocr Pract; 2007; 13(1):5-10. PubMed ID: 17360294
[TBL] [Abstract][Full Text] [Related]
4. Isolated use of vibration perception thresholds and semmes-weinstein monofilament in diagnosing diabetic polyneuropathy: "the North Catalonia diabetes study".
Jurado J; Ybarra J; Pou JM
Nurs Clin North Am; 2007 Mar; 42(1):59-66. PubMed ID: 17270590
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of a new device in the assessment of peripheral sensory neuropathy in diabetes.
Bracewell N; Game F; Jeffcoate W; Scammell BE
Diabet Med; 2012 Dec; 29(12):1553-5. PubMed ID: 22672257
[TBL] [Abstract][Full Text] [Related]
6. Review of Economic Submissions to NICE Medical Technologies Evaluation Programme.
Alshreef A; Jenks M; Green W; Dixon S
Appl Health Econ Health Policy; 2016 Dec; 14(6):623-634. PubMed ID: 27480537
[TBL] [Abstract][Full Text] [Related]
7. The value of the Rydel-Seiffer tuning fork as a predictor of diabetic polyneuropathy compared with a neurothesiometer.
Kästenbauer T; Sauseng S; Brath H; Abrahamian H; Irsigler K
Diabet Med; 2004 Jun; 21(6):563-7. PubMed ID: 15154940
[TBL] [Abstract][Full Text] [Related]
8. The XprESS Multi-Sinus Dilation System for the Treatment of Chronic Sinusitis: A NICE Medical Technology Guidance.
Jenks M; Willits I; Turner EE; Hewitt N; Arber M; Cole H; Craig J; Sims A
Appl Health Econ Health Policy; 2017 Oct; 15(5):567-582. PubMed ID: 28669043
[TBL] [Abstract][Full Text] [Related]
9. Opportunity costs and local health service spending decisions: a qualitative study from Wales.
Karlsberg Schaffer S; Sussex J; Hughes D; Devlin N
BMC Health Serv Res; 2016 Mar; 16():103. PubMed ID: 27012523
[TBL] [Abstract][Full Text] [Related]
10. The geko™ electro-stimulation device for venous thromboembolism prophylaxis: a NICE medical technology guidance.
Summers JA; Clinch J; Radhakrishnan M; Healy A; McMillan V; Morris E; Rua T; Ofuya M; Wang Y; Dimmock PW; Lewis C; Peacock JL; Keevil SF
Appl Health Econ Health Policy; 2015 Apr; 13(2):135-47. PubMed ID: 25403719
[TBL] [Abstract][Full Text] [Related]
11. E-vita open plus for treating complex aneurysms and dissections of the thoracic aorta: a NICE medical technology guidance.
Radhakrishnan M; Peacock J; Rua T; Clough RE; Ofuya M; Wang Y; Morris E; Lewis C; Keevil S
Appl Health Econ Health Policy; 2014 Oct; 12(5):485-95. PubMed ID: 25056415
[TBL] [Abstract][Full Text] [Related]
12. The Debrisoft(®) Monofilament Debridement Pad for Use in Acute or Chronic Wounds: A NICE Medical Technology Guidance.
Meads C; Lovato E; Longworth L
Appl Health Econ Health Policy; 2015 Dec; 13(6):583-94. PubMed ID: 26315567
[TBL] [Abstract][Full Text] [Related]
13. Validation of Neuropad in the Assessment of Peripheral Diabetic Neuropathy in Patients with Diabetes Mellitus Versus the Michigan Neuropathy Screening Instrument, 10g Monofilament Application and Biothesiometer Measurement.
Zografou I; Iliadis F; Sambanis C; Didangelos T
Curr Vasc Pharmacol; 2020; 18(5):517-522. PubMed ID: 31340739
[TBL] [Abstract][Full Text] [Related]
14. Non-invasive assessment of vibration perception and protective sensation in people with diabetes mellitus: inter- and intra-rater reliability.
Lanting SM; Spink MJ; Tehan PE; Vickers S; Casey SL; Chuter VH
J Foot Ankle Res; 2020; 13():3. PubMed ID: 31988664
[TBL] [Abstract][Full Text] [Related]
15. How should cost-effectiveness analysis be used in health technology coverage decisions? Evidence from the National Institute for Health and Clinical Excellence approach.
Williams I; Bryan S; McIver S
J Health Serv Res Policy; 2007 Apr; 12(2):73-9. PubMed ID: 17407655
[TBL] [Abstract][Full Text] [Related]
16. Virtual Touch™ Quantification to Diagnose and Monitor Liver Fibrosis in Hepatitis B and Hepatitis C: A NICE Medical Technology Guidance.
Summers JA; Radhakrishnan M; Morris E; Chalkidou A; Rua T; Patel A; McMillan V; Douiri A; Wang Y; Ayis S; Higgins J; Keevil S; Lewis C; Peacock J
Appl Health Econ Health Policy; 2017 Apr; 15(2):139-154. PubMed ID: 27601240
[TBL] [Abstract][Full Text] [Related]
17. NerveCheck: An inexpensive quantitative sensory testing device for patients with diabetic neuropathy.
Ponirakis G; Odriozola MN; Odriozola S; Petropoulos IN; Azmi S; Fadavi H; Alam U; Asghar O; Marshall A; Miro A; Kheyami A; Al-Ahmar A; Odriozola MB; Odriozola A; Malik RA
Diabetes Res Clin Pract; 2016 Mar; 113():101-7. PubMed ID: 26830855
[TBL] [Abstract][Full Text] [Related]
18. The MAGEC system for spinal lengthening in children with scoliosis: A NICE Medical Technology Guidance.
Jenks M; Craig J; Higgins J; Willits I; Barata T; Wood H; Kimpton C; Sims A
Appl Health Econ Health Policy; 2014 Dec; 12(6):587-99. PubMed ID: 25172432
[TBL] [Abstract][Full Text] [Related]
19. Predictors of vibration perception threshold in type 2 diabetic patients with proliferative retinopathy.
Magri CJ; Calleja N; Buhagiar G; Fava S; Vassallo J
Postgrad Med J; 2011 Oct; 87(1032):658-63. PubMed ID: 21954032
[TBL] [Abstract][Full Text] [Related]
20. The Memokath-051 Stent for the Treatment of Ureteric Obstruction: A NICE Medical Technology Guidance.
Eaton Turner E; Jenks M; McCool R; Marshall C; Millar L; Wood H; Peel A; Craig J; Sims AJ
Appl Health Econ Health Policy; 2018 Aug; 16(4):445-464. PubMed ID: 29616460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
